Covid-19 roundup: Moderna offers glimpse at durability data; Bribery scandals mar Sinovac's reputation

Amber Tong

Nicole DeFeudis

Editor

While Moderna has said its vaccine is 94.1% effective at preventing symptomatic Covid-19, a big question still remains: How long does protection last? …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna offers glimpse at durability data; Bribery scandals mar Sinovac's reputation

Amber Tong

Nicole DeFeudis

Editor

Sign up to read this article for free.

Novartis to cut 139 jobs in NJ as part of commercial refocus

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

Norbert Bischofberger's time as Kronos CEO ends as biotech seeks new life

Bristol Myers sues the federal government over 340B, following other drugmakers

Covid-19 roundup: Mod­er­na of­fers glimpse at dura­bil­i­ty da­ta; Bribery scan­dals mar Sino­vac's rep­u­ta­tion

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: Moderna offers glimpse at durability data; Bribery scandals mar Sinovac's reputation